Specifying objectives and outcomes for clinical trials

被引：10

作者：

Gebski, V ^{[1
]}

Marschner, I ^{[1
]}

Keech, AC ^{[1
]}

机构：

[1] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW 1450, Australia

来源：

MEDICAL JOURNAL OF AUSTRALIA | 2002年 / 176卷 / 10期

关键词：

D O I：

10.5694/j.1326-5377.2002.tb04522.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：491 / 492

页数：2

共 7 条

[1] Considerations in the evaluation of surrogate endpoints in clinical trials: Summary of a National Institutes of Health Workshop [J].

De Gruttola, VG ;

Clax, P ;

DeMets, DL ;

Downing, GJ ;

Ellenberg, SS ;

Friedman, L ;

Gail, MH ;

Prentice, R ;

Wittes, J ;

Zeger, SL .

CONTROLLED CLINICAL TRIALS, 2001, 22 (05) :485-502

[2] STATISTICAL VALIDATION OF INTERMEDIATE END-POINTS FOR CHRONIC DISEASES [J].

FREEDMAN, LS ;

GRAUBARD, BI ;

SCHATZKIN, A .

STATISTICS IN MEDICINE, 1992, 11 (02) :167-178

[3] Randomised controlled trials: elements of a good study [J].

Gebski, VJ ;

Beller, EM ;

Keech, AC .

MEDICAL JOURNAL OF AUSTRALIA, 2001, 175 (05) :272-274

[4] Scientific background and rationale for a randomised controlled trial [J].

Ghersi, D ;

Gebski, VJ ;

Keech, AC .

MEDICAL JOURNAL OF AUSTRALIA, 2001, 175 (07) :386-386

[5] Selecting participants for clinical trials [J].

Keech, AC ;

Gebski, VJ .

MEDICAL JOURNAL OF AUSTRALIA, 2001, 175 (09) :490-+

[6] The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials [J].

Moher, D ;

Schulz, KF ;

Altman, D .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (15) :1987-1991

[7]

Piantadosi S., 1997, CLIN TRIALS METHODOL

← 1 →